- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Most Popular Stocks
Global Pharmaceuticals & Biotech Most Popular Stocks
Results
3043
Most Popular Stocks on the market
3043 companies
Krystal Biotech
Market Cap: US$4.7b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$161.15
7D
0.3%
1Y
-9.7%
Peptron
Market Cap: ₩6.6t
Engages in the development of peptide-based medicines.
A087010
₩277,500.00
7D
-4.1%
1Y
418.7%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥33.0b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥70.42
7D
0.6%
1Y
86.2%
Zhejiang Huahai Pharmaceutical
Market Cap: CN¥32.8b
Operates as a pharmaceutical company in China and internationally.
600521
CN¥20.82
7D
-9.3%
1Y
16.8%
Alkermes
Market Cap: US$4.6b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$27.13
7D
-5.0%
1Y
-0.1%
Arrowhead Pharmaceuticals
Market Cap: US$4.5b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$31.66
7D
0.5%
1Y
61.4%
Livzon Pharmaceutical Group
Market Cap: CN¥32.2b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥38.23
7D
-2.6%
1Y
-0.5%
InnoCare Pharma
Market Cap: HK$34.9b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.55
7D
6.8%
1Y
188.7%
China Medical System Holdings
Market Cap: HK$34.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.24
7D
-5.2%
1Y
70.5%
Genscript Biotech
Market Cap: HK$34.7b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$15.68
7D
-8.1%
1Y
21.6%
Sotera Health
Market Cap: US$4.5b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$15.54
7D
-2.7%
1Y
-6.3%
Sumitomo Pharma
Market Cap: JP¥655.5b
Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,594.00
7D
-2.6%
1Y
161.7%
Arcellx
Market Cap: US$4.4b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$78.41
7D
-2.0%
1Y
-6.8%
Jyong Biotech
Market Cap: US$4.3b
A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.
MENS
US$59.25
7D
14.5%
1Y
n/a
Siegfried Holding
Market Cap: CHF 3.4b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 78.20
7D
-7.6%
1Y
-32.7%
Dong-E-E-JiaoLtd
Market Cap: CN¥30.4b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥47.58
7D
-0.5%
1Y
-19.5%
Vaxcyte
Market Cap: US$4.3b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$32.14
7D
-1.4%
1Y
-71.2%
Simcere Pharmaceutical Group
Market Cap: HK$33.1b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.48
7D
-3.0%
1Y
92.3%
Camurus
Market Cap: SEK 39.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 666.50
7D
-4.2%
1Y
2.9%
Hualan Biological Engineering
Market Cap: CN¥29.3b
Researches, develops, produces, and commercializes blood products, vaccines, and genetic engineering products in China and internationally.
002007
CN¥16.05
7D
-1.0%
1Y
-2.2%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥29.3b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥43.81
7D
-0.5%
1Y
35.8%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥29.3b
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
688266
CN¥106.50
7D
0.9%
1Y
79.1%
Protagonist Therapeutics
Market Cap: US$4.1b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$64.70
7D
4.1%
1Y
44.0%
Betta Pharmaceuticals
Market Cap: CN¥29.3b
Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.
300558
CN¥67.80
7D
1.1%
1Y
68.3%
Jiangsu Nhwa Pharmaceutical
Market Cap: CN¥29.2b
Engages in production, marketing, and services related to central nervous system drugs in China.
002262
CN¥27.74
7D
1.1%
1Y
11.0%
PharmaResearch
Market Cap: ₩5.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩578,000.00
7D
-3.2%
1Y
200.3%
Kangmei Pharmaceutical
Market Cap: CN¥28.1b
Produces and sells Chinese herbal medicines in China.
600518
CN¥2.02
7D
-2.9%
1Y
6.9%
BrightGene Bio-Medical Technology
Market Cap: CN¥28.1b
A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.
688166
CN¥58.06
7D
-38.4%
1Y
96.0%
MGI Tech
Market Cap: CN¥28.0b
Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.
688114
CN¥67.10
7D
0.09%
1Y
57.1%
Cohance Lifesciences
Market Cap: ₹344.3b
Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.
COHANCE
₹869.30
7D
-4.4%
1Y
-25.0%
Ipca Laboratories
Market Cap: ₹342.6b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.
IPCALAB
₹1,371.20
7D
-4.8%
1Y
-7.2%
China Resources Pharmaceutical Group
Market Cap: HK$30.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.73
7D
-3.3%
1Y
-15.8%
Akero Therapeutics
Market Cap: US$3.8b
Engages in the development of treatments for patients with serious metabolic diseases in the United States.
AKRO
US$46.22
7D
0.04%
1Y
57.5%
LigaChem Biosciences
Market Cap: ₩5.3t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩142,400.00
7D
-7.2%
1Y
45.6%
Grand Pharmaceutical Group
Market Cap: HK$29.4b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.36
7D
-3.8%
1Y
72.0%
United Laboratories International Holdings
Market Cap: HK$29.3b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$14.82
7D
-6.3%
1Y
52.2%